We convert technology research created by government organisations into civilian applications
Demystifying the ‘spinning-out’ process.
Raj joined the Ploughshare board in 2022, bringing a wealth of technical knowledge and more than 20 years of experience as an entrepreneur, investor and biomedical research specialist.
After gaining an MA and DPhil from Oxford University, he pursued a successful academic career in molecular medicine before co-founding Oxford GlycoSciences (IPO on LSE and NASDAQ). Following its sale to UCB-Celltech, he became Chairman of Galapagos nv, a member of the Supervisory Board of the Novartis Venture Fund and a founding Director of Celldex Therapeutics.
Raj also serves on the board of several other companies including Arrakis Therapeutics, Aura Biosciences, and Levicept.
© Ploughshare Innovations Ltd 2024. Registered in England and Wales No. 04401901
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |